Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1276
Toro Company
TTC
$9.34B
| $18.8M | ﹤0.01% |
239,294
-55,116
| -19% | -$4.07M |
2013 Q2
50 quarters
|
|
1277
Saic
SAIC
$5.25B
| $18.8M | ﹤0.01% |
186,317
+120,987
| +185% | +$11.6M |
2013 Q4
48 quarters
|
|
1278
PUT
Akamai
AKAM
$15.7B
| $18.7M | ﹤0.01% |
214,600
+78,700
| +58% | +$6.47M |
2024 Q3
5 quarters
|
|
1279
Tenet Healthcare
THC
$20.8B
| $18.7M | ﹤0.01% |
94,159
-36,415
| -28% | -$7.36M |
2013 Q2
50 quarters
|
|
1280
PUT
Fluor
FLR
$6.67B
| $18.7M | ﹤0.01% |
471,100
-61,700
| -12% | -$2.73M |
2025 Q3
1 quarter
|
|
1281
PUT
EOG Resources
EOG
$74.2B
| $18.6M | ﹤0.01% |
177,400
| – | – |
2024 Q3
5 quarters
|
|
1282
MGM Resorts International
MGM
$7.67B
| $18.6M | ﹤0.01% |
508,952
-774,102
| -60% | -$26.3M |
2013 Q2
50 quarters
|
|
1283
New Oriental
EDU
$8.59B
| $18.5M | ﹤0.01% |
336,408
-95,156
| -22% | -$5.22M |
2015 Q2
42 quarters
|
|
1284
CALL
Visa
V
$677B
| $18.5M | ﹤0.01% |
52,700
+15,300
| +41% | +$5.21M |
2022 Q4
12 quarters
|
|
1285
APi Group
APG
$17.5B
| $18.5M | ﹤0.01% |
482,920
-168,483
| -26% | -$6.23M |
2022 Q1
15 quarters
|
|
1286
Federal Realty Investment Trust
FRT
$9.27B
| $18.4M | ﹤0.01% |
182,875
+15,163
| +9% | +$1.49M |
2013 Q2
50 quarters
|
|
1287
Globant
GLOB
$1.52B
| $18.4M | ﹤0.01% |
281,429
-171,902
| -38% | -$10.8M |
2020 Q3
21 quarters
|
|
1288
PUT
HSBC
HSBC
$329B
| $18.4M | ﹤0.01% |
233,800
| – | – |
2025 Q2
2 quarters
|
|
1289
Futu Holdings
FUTU
$14.3B
| $18.4M | ﹤0.01% |
111,963
-28,457
| -20% | -$4.88M |
2020 Q2
22 quarters
|
|
1290
MasTec
MTZ
$17.3B
| $18.3M | ﹤0.01% |
84,289
-41,174
| -33% | -$8.64M |
2016 Q1
39 quarters
|
|
1291
Jones Lang LaSalle
JLL
$14.1B
| $18.3M | ﹤0.01% |
54,294
-44,931
| -45% | -$14.1M |
2013 Q2
50 quarters
|
|
1292
Zillow
Z
$6.16B
| $18.3M | ﹤0.01% |
267,769
+50,607
| +23% | +$3.66M |
2015 Q3
41 quarters
|
|
1293
PUT
eBay
EBAY
$47.3B
| $18.3M | ﹤0.01% |
209,700
-250,000
| -54% | -$21.6M |
2025 Q2
2 quarters
|
|
1294
Equity Lifestyle Properties
ELS
$11.3B
| $18.2M | ﹤0.01% |
300,632
-82,381
| -22% | -$5.09M |
2013 Q2
50 quarters
|
|
1295
Roivant Sciences
ROIV
$25.8B
| $18.2M | ﹤0.01% |
839,279
-369,476
| -31% | -$7.29M |
2022 Q1
15 quarters
|
|
1296
First Horizon
FHN
$11.1B
| $18.2M | ﹤0.01% |
761,147
-1,455,263
| -66% | -$32.4M |
2013 Q2
50 quarters
|
|
1297
Viking Therapeutics
VKTX
$3.76B
| $18.2M | ﹤0.01% |
516,656
+55,849
| +12% | +$1.98M |
2017 Q4
32 quarters
|
|
1298
Wyndham Hotels & Resorts
WH
$5.33B
| $18.1M | ﹤0.01% |
239,615
+104,245
| +77% | +$7.86M |
2018 Q2
30 quarters
|
|
1299
CALL
Occidental Petroleum
OXY
$58.1B
| $18.1M | ﹤0.01% |
440,000
+140,000
| +47% | +$5.84M |
2025 Q2
2 quarters
|
|
1300
Upwork
UPWK
$1.01B
| $18.1M | ﹤0.01% |
912,840
-15,206
| -2% | -$279K |
2018 Q4
28 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.